OSE Immunotherapeutics SA

EPA:OSE.PA

6.05 (EUR) • At close June 5, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2024 Q42024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q22012 Q42012 Q2
Operating Activities:
Net Income -19.7357.175-11.143-11.86-15.781-1.979-5.362-11.488-13.441-3.114-5.1660.514-3.3878.877-4.163-6.34-3.8424.506-2.642-2.942-2.18-0.655-0.127-0.123-0.718-0.718
Depreciation & Amortization 01.6640.5411.8281.7741.671.7480.8440.3880.3420.2620.220.0560.060.0390.0840.0840.0230.0890.01000000
Deferred Income Tax 00-0.139-0.084-0.131-0.133-0.092-0.27400-0.1153.17800000000000000
Stock Based Compensation 000.4721.5621.9481.1821.0492.7241.1071.1761.1950.6730.4350.5420.9840.521-0.0670.7470.5141.34300.1350.006000
Change In Working Capital -5.5977.5770.303-1.138-2.037-1.105-0.9591.9840.249-3.442-0.4078.962-0.739-3.851-4.1417.397.97-7.6-0.747-0.2780.6430.12-0.0230.0320.0240.024
Accounts Receivables 0-0.4440.748-0.17-0.003-0.3660.038-0.34002.581-1.0750000000000000.0240.024
Change In Inventory 00-1.0480000000-0.034000000000000000
Change In Accounts Payables 0-0.954-0.1230.882-5.0854.018-3.4752.796000.672-0.30900000000000000
Other Working Capital -5.5978.9750.303-1.853.051-4.7572.478-0.4720.249-3.442-3.62610.346-0.739-3.851-4.1417.397.97-7.6-0.747-0.2780.6430.12-0.0230.032-0.001-0.001
Other Non Cash Items 7.1340.2171.792.4718.48-0.6868.4411.4041.38-4.195-2.132.748-2.0761.16-1.368-1.002-0.902-20.237-0.0010.04-0.0010.0010.025-0.026-0.002-0.002
Operating Cash Flow -18.19366.633-8.037-11.727-16.331-1.921-3.157-6.762-10.317-9.233-4.82713.798-5.7116.788-8.6490.6533.245-2.561-2.787-1.827-1.538-0.399-0.119-0.117-0.697-0.697
Investing Activities:
Investments In Property Plant And Equipment -0.059-0.018-0.0160-0.12-0.154-0.345-0.127-0.093-0.117-0.137-0.199-0.17-0.423-0.332-0.021-0.027-0.003-0.0430-0.02500000
Acquisitions Net 00-0.0620.06200-0.7920.7920000000003.1630000000.2660.266
Purchases Of Investments -46.561-0.006-0.2750000.361-0.361000.104-0.104000000000000-0.011-0.011
Sales Maturities Of Investments 0000.0480.0960.2040-0.431002.8690.0260000000000000.010.01
Other Investing Activites 54.625-54.89-0.6010.110.0960.204-0.3550.4310.014-0.308-0.147-0.0370.0190.0160.06-0.0062.9210.051-5.772-0.1420000-0.001-0.001
Investing Cash Flow 8.005-54.914-0.6170.11-0.0240.05-1.1310.304-0.079-0.4252.689-0.314-0.151-0.407-0.272-0.0272.8943.211-5.815-0.142-0.0250.279000.2640.264
Financing Activities:
Debt Repayment 0.992-4.3281.3080.99611.19010.0465.195004.650.524-0.303-0.1810.982.119-0.411-0.4010000000.4020.402
Common Stock Issued 0.9420.21511.170.4870.00600.0080.25700000.0300.0190.0160.136000000000
Common Stock Repurchased 00000000000.019-0.019-0.025-0.042-0.062-0.005-0.046-0.531-0.142-0.179-0.08500000
Dividends Paid 00000000000000000000000000
Other Financing Activities -0.858-0.421-0.169-0.468-0.414-0.5150.549-1.09816.8446.736-0.2510.045-0.025-0.046-0.006-0.005-0.0080.008-0.42719.231-0.0912.8690.0710.26-0.001-0.001
Financing Cash Flow 1.076-4.53412.3091.01510.782-0.51510.6034.35416.8446.7364.4180.505-0.323-0.2690.9312.125-0.329-0.905-0.42719.231-0.0912.8690.0710.260.4010.401
Other Information:
Effect Of Forex Changes On Cash 00-0.00125.62-25.6233.579-33.57929.368-29.36825.842-25.8429.573-9.5739.646-9.64714.886-14.8859.33-9.3280.0010.008-0.00800-0.001-0.001
Net Change In Cash 057.0743.654-10.602-5.573-2.3866.315-2.1046.448-2.9222.2823.562-15.75815.758-17.63717.637-9.0759.075-18.35717.263-1.6462.741-0.3510.072-0.064-0.064
Cash At End Of Period 16.74575.74618.67215.01825.6231.19333.57927.26429.36822.9225.8421.817015.758017.63709.075018.3571.0952.741-0.0240.3270.1850.185